You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-alcoholic Fatty Liver Disease

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Simple Steatosis Non Fatty Liver Trial in Cairo (N acetyl cysteine with weight reduction)

Recruiting
  • Simple Steatosis Non Fatty Liver
  • N acetyl cysteine with weight reduction
  • Cairo, Egypt
    NHTMRI
Oct 18, 2022

Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Machine Learning
  • 10-year ASCVD risk estimation
  • Nanjing, Jiangsu, China
    Division of Endocrinology, the Affiliated Drum Tower Hospital of
Sep 29, 2022

Nonalcoholic Fatty Liver Disease, Type 2 Diabetes Trial in Riyadh

Recruiting
  • Nonalcoholic Fatty Liver Disease
  • Type 2 Diabetes Mellitus
    • Riyadh, Select A State Or Province, Saudi Arabia
      King Fahad Medical City
    Jan 25, 2023

    Effects of Bacillus Coagulans TCI711 Supplementation on Liver and Gut Microbiota Function in Non-alcoholic Fatty Liver Disease

    Recruiting
    • Effects of Bacillus Coagulans TCI711 Supplementation on Liver and Gut Microbiota Function in Non-alcoholic Fatty Liver Disease Patients
    • Bacillus Coagulans
    • Placebo
    • Taipei city, Taiwan
      Taipei Medical university
    Nov 22, 2022

    Brain Function Evaluation in Non-alcoholic Fatty Liver Disease

    Enrolling by invitation
    • Non-Alcoholic Fatty Liver Disease
    • Cognitive Impairment
    • Cognitive assessment, functional magnetic resonance imaging
    • Nanjing, Jiangsu, China
      at Division of Endocrinology, the Affiliated Drum Tower Hospital
    Oct 9, 2022

    Bariatric Surgery on NASH

    Active, not recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Obesity
      • Hellerup, Denmark
        Center for Clinical Metabolic Research
      Nov 2, 2022

      UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)

      Recruiting
      • Non Alcoholic Fatty Liver Disease
      • UDFF
      • Angers, France
        Angers university hospital
      Oct 6, 2023

      Chronic Hepatitis B, Non-alcoholic Fatty Liver Disease Trial in Taipei (exercise)

      Enrolling by invitation
      • Chronic Hepatitis B
      • Non-alcoholic Fatty Liver Disease
      • exercise
      • Taipei, Zhongzheng Dist., Taiwan
        National Taiwan University Hospital
      Jul 13, 2023

      Non-alcoholic Fatty Liver Disease Trial in Zagazig (Rybelsus Oral Product, Ozempic Injectable Product, Tocopherol and/or Actos)

      Recruiting
      • Non-alcoholic Fatty Liver Disease
      • Rybelsus Oral Product
      • +2 more
      • Zagazig, Sharkia, Egypt
        Zagazig University
      Apr 1, 2023

      Liver Diseases Trial (Liver Fine-Needle Aspiration)

      Not yet recruiting
      • Liver Diseases
      • Liver Fine-Needle Aspiration
      • (no location specified)
      Nov 29, 2023

      Renal Impairment Trial (level of serun adiponectin)

      Not yet recruiting
      • Renal Impairment
      • level of serun adiponectin
      • (no location specified)
      Sep 23, 2022

      Non-Alcoholic Fatty Liver Disease, Steatosis of Liver Trial in Ramat Gan (Ultra Low Dose CT, Fat quantification MRI)

      Enrolling by invitation
      • Non-Alcoholic Fatty Liver Disease
      • Steatosis of Liver
      • Ultra Low Dose CT
      • Fat quantification MRI
      • Ramat Gan, Israel
        Prof. Noam Tau
      Jan 29, 2023

      NASH With Fibrosis Trial in Beijing

      Not yet recruiting
      • NASH With Fibrosis
        • Beijing, Beijing, China
          Beijing Tsinghua Changgung Hospital
        Nov 3, 2023

        Non-Alcoholic Fatty Liver Disease Trial in Orlando (Standard of care liver biopsy, Fibroscan, Biospecimen Collection)

        Recruiting
        • Non-Alcoholic Fatty Liver Disease
        • Standard of care liver biopsy
        • +2 more
        • Orlando, Florida
          AdventHealth Translational Research Institute
        Aug 2, 2022

        Non-alcoholic Fatty Liver Disease, Obesity Trial (BI 3006337, Placebo matching BI 3006337)

        Not yet recruiting
        • Non-alcoholic Fatty Liver Disease
        • Obesity
        • BI 3006337
        • Placebo matching BI 3006337
        • (no location specified)
        Jul 25, 2023

        Hypercholesterolemia Trial (HSK31679 low dose, HSK31679 medium dose, HSK31679 high dose)

        Not yet recruiting
        • Hypercholesterolemia
        • HSK31679 low dose
        • +4 more
        • (no location specified)
        Mar 20, 2023

        Velacur System in Comparison to MRE & MRI-PDFF in Liver Disease

        Not yet recruiting
        • Non-alcoholic Fatty Liver Disease (NAFLD)
        • Velacur
        • Flowood, Mississippi
        • +1 more
        Jun 14, 2023

        Non-Alcoholic Fatty Liver Disease Trial in Kurdistan (Multiviamins and minerals, Placebo)

        Completed
        • Non-Alcoholic Fatty Liver Disease
        • Multiviamins and minerals
        • Placebo
        • Kurdistan, Kalar, Iraq
          Hawal Fateh
        Jun 8, 2023

        Hyperoxaluria, Nonalcoholic Fatty Liver Disease, Kidney Stone Trial in United States (BMN 255, Placebo)

        Recruiting
        • Hyperoxaluria
        • +2 more
        • BMN 255
        • Placebo
        • Birmingham, Alabama
        • +6 more
        Nov 16, 2023

        Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed

        Recruiting
        • Non-Alcoholic Fatty Liver Disease
        • Abdominal ultrasound and lipid profile
        • Sohag, Egypt
          Sohag University Hospital
        Aug 3, 2022

        Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Trial in New York (Diazoxide oral suspension, 1 mg per

        Recruiting
        • Hyperinsulinemia
        • +3 more
        • Diazoxide oral suspension, 1 mg per kg per dose
        • +3 more
        • New York, New York
          Columbia University Irving Medical Center
        Feb 6, 2023

        Obesity, NAFLD Trial (Usual Care Control Group, Moderate-intensity Exercise Intervention, Vigorous-intensity Exercise

        Not yet recruiting
        • Obesity
        • NAFLD
        • Usual Care Control Group
        • +2 more
        • (no location specified)
        Nov 3, 2023

        Non-Alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, Obesity Trial in Richmond (Mindfulness Based Stress Reduction

        Recruiting
        • Non-Alcoholic Fatty Liver Disease
        • +2 more
        • Mindfulness Based Stress Reduction (MBSR)
        • Richmond, Virginia
          Virginia Commonwealth University
        Jul 22, 2022

        Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation Trial in Amsterdam

        Recruiting
        • Non Alcoholic Steatohepatitis
        • +8 more
        • LFMT-capsules
        • Amsterdam, Noord-Holland, Netherlands
          Amsterdam UMC
        Apr 6, 2023

        Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis Trial in Argentina, Germany, United States (LYS006, LYS006 +

        Terminated
        Has Results
        • Non-alcoholic Fatty Liver Disease
        • Nonalcoholic Steatohepatitis
        • Coronado, California
        • +9 more
        Jan 10, 2023